Shilpa Medicare
Shilpa Medicare Performance
Day Range
- Low 359.10
- High 370.80
52 Week Range
- Low 222.60
- High 397.00
- Open Price359.10
- Previous Close357.80
- Volume211231
Start SIP in Shilpa Medicare
Start SIPShilpa Medicare Investment Rating
-
Master Rating:
-
Shilpa Medicare Limited has an operating revenue of Rs. 1,099.21 Cr. on a trailing 12-month basis. An annual revenue de-growth of -8% needs improvement, Pre-tax margin of -3% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 18% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -6% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 75 | 84 | 66 | 52 | 69 | 61 | 73 |
| Operating Expenses Qtr Cr | 67 | 68 | 80 | 62 | 93 | 56 | 74 |
| Operating Profit Qtr Cr | 7 | 15 | -14 | -10 | -24 | 5 | -2 |
| Depreciation Qtr Cr | 13 | 12 | 12 | 12 | 12 | 10 | 10 |
| Interest Qtr Cr | 5 | 7 | 7 | 7 | 5 | 3 | 2 |
| Tax Qtr Cr | 5 | 3 | 2 | -7 | -4 | 0 | 0 |
| Net Profit Qtr Cr | 7 | 8 | -29 | -5 | -17 | 108 | 35 |
Shilpa Medicare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹364.67
- 50 Day
- ₹356.91
- 100 Day
- ₹342.82
- 200 Day
- ₹329.55
- 20 Day
- ₹367.86
- 50 Day
- ₹353.72
- 100 Day
- ₹351.47
- 200 Day
- ₹302.61
Shilpa Medicare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 373.73 |
| Second Resistance | 378.12 |
| Third Resistance | 385.43 |
| RSI | 53.83 |
| MFI | 56.24 |
| MACD Single Line | 5.28 |
| MACD | 3.76 |
| Support | |
|---|---|
| First Resistance | 362.03 |
| Second Resistance | 354.72 |
| Third Resistance | 350.33 |
Shilpa Medicare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 220,439 | 11,207,119 | 50.84 |
| Week | 208,817 | 10,125,527 | 48.49 |
| 1 Month | 442,236 | 20,612,597 | 46.61 |
| 6 Month | 882,738 | 32,131,659 | 36.4 |
Shilpa Medicare Result Highlights
Shilpa Medicare Synopsis
NSE-Medical-Diversified
Shilpa Medicare L is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 247.70 Cr. and Equity Capital is Rs. 8.68 Cr. for the Year ended 31/03/2023. Shilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739.| Market Cap | 3,206 |
| Sales | 276 |
| Shares in Float | 4.34 |
| No of funds | 47 |
| Yield | 0.09 |
| Book Value | 1.51 |
| U/D Vol ratio | 1.3 |
| LTDebt / Equity | 6 |
| Alpha | 0.06 |
| Beta | 0.8 |
Shilpa Medicare
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 50.01% | 50.01% | 50.01% | 50.01% |
| Mutual Funds | 0.04% | 0.05% | ||
| Foreign Portfolio Investors | 8.6% | 10.26% | 13.73% | 15.32% |
| Individual Investors | 25.4% | 26.81% | 24.05% | 21.85% |
| Others | 15.95% | 12.92% | 12.21% | 12.77% |
Shilpa Medicare Management
| Name | Designation |
|---|---|
| Mr. Omprakash Inani | Chairman |
| Mr. Vishnukant Chaturbhuj Bhutada | Managing Director |
| Mr. Sharath Reddy Kalakota | Whole Time Director |
| Ms. Sirisha Chintapalli | Independent Woman Director |
| Mr. Hetal Madhukant Gandhi | Independent Director |
| Mr. Arvind Vasudeva | Independent Director |
| Dr. Kamal K Sharma | Independent Director |
| Dr. Anita Bandyopadhyay | Independent Director |
Shilpa Medicare Forecast
Price Estimates
Shilpa Medicare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-10 | Quarterly Results | |
| 2023-08-10 | Quarterly Results | |
| 2023-06-23 | Rights issue of Equity Shares | |
| 2023-05-25 | Audited Results | |
| 2023-02-14 | Quarterly Results |
Shilpa Medicare FAQs
What is Share Price of Shilpa Medicare ?
Shilpa Medicare share price is ₹369 As on 04 December, 2023 | 22:50
What is the Market Cap of Shilpa Medicare ?
The Market Cap of Shilpa Medicare is ₹3206 Cr As on 04 December, 2023 | 22:50
What is the P/E ratio of Shilpa Medicare ?
The P/E ratio of Shilpa Medicare is -269.2 As on 04 December, 2023 | 22:50
What is the PB ratio of Shilpa Medicare ?
The PB ratio of Shilpa Medicare is 1.8 As on 04 December, 2023 | 22:50